Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-076998)

Filing Details

Accession Number:: 0001104659-21-076998
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-04 16:06:09
Reporting Period:: 2021-06-02

Accepted Time:: 2021-06-04 16:06:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1824293	Vallon Pharmaceuticals Inc.	VLON	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1398278	M. Leanne Kelly	C/O Vallon Pharmaceuticals, Inc. 100 N. 18Th Street, Suite 300 Philadelphia PA 19103	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-02	3,657	$4.00	3,657	No	4	P	Direct
Common Stock	Acquisiton	2021-06-03	1,085	$4.05	4,742	No	4	P	Direct
Common Stock	Acquisiton	2021-06-04	1,508	$4.08	6,250	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct